Global medical technology firm Hill-Rom has acquired medical diagnostic devices manufacturer Welch Allyn in a cash and stock deal valued at $2.5bn.

Under the agreement announced in June, Welch Allyn shareholders received $1.625bn in cash and nearly 8.1 million newly issued shares of Hill-Rom common stock.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Hill-Rom president John Greisch said: "We are excited to officially welcome our 2,500 Welch Allyn colleagues to the Hill-Rom family.

"Our companies share similar legacies of innovation, quality and employees who are passionate about enhancing outcomes for patients and caregivers."

"Our companies share similar legacies of innovation, quality and employees who are passionate about enhancing outcomes for patients and caregivers."

The combined business is expected to provide a broad spectrum of novel solutions to a patient-centric, global customer base focused on quality and efficiency.

In particular, the entity will expand Hill-Rom’s product portfolio with point of care diagnostics and testing, helping the company to offer better patient care solutions for hospitals, physician offices and other care settings, reducing healthcare costs for its customers.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Headquartered in Skaneateles Falls, New York, Welch Allyn produces medical diagnostic equipment and a diversified portfolio of devices, which assess, diagnose, treat and manage a wide variety of illnesses and diseases.

The firm also manufactures physical examination instruments, accessories and EMR connected vital signs, as well as cardiac monitoring solutions. The company employs 2,600 people in 26 different countries.

According to Hill-Rom, the acquisition is not expected to be materially accretive to its earnings this year, but will add more than 10% to adjusted earnings per share for 2016, beginning 1 October.

Employing approximately 10,000 people worldwide, Hill-Rom offers patient care solutions in areas, comprising advancing mobility, wound care and prevention, clinical workflow, surgical safety, efficiency and respiratory health.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact